May 28, 2015
Among patients undergoing transcatheter aortic valve replacement, those who developed infective endocarditis had a high rate of mortality and other poor outcomes, according to recent findings.
The researchers studied the incidence, predictors, clinical characteristics, management and outcomes in 53 patients who experienced infective endocarditis after TAVR from a cohort of 7,944 patients followed for a mean of 1.1 years. The incidence rate of infective endocarditis was 0.67% overall and 0.5% within the first year after TAVR. The mean duration between TAVR and incidence was 6 months (interquartile range, 1-14 months).